Data as of Sep 19
| +0.05 / +1.89%|
The 2 analysts offering 12-month price forecasts for Alexza Pharmaceuticals Inc have a median target of 7.75, with a high estimate of 10.00 and a low estimate of 5.50. The median estimate represents a +187.04% increase from the last price of 2.70.
The current consensus among 2 polled investment analysts is to Buy stock in Alexza Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.